Cedric O'Gorman
Geen lopende functies
Vermogen: 47 063 $ op 31-03-2024
Profiel
Cedric O'Gorman worked as Senior VP-Clinical Development & Medical Affairs at Axsome Therapeutics, Inc. from 2017 to 2021.
Prior to that, he was Vice President-Medical Affairs at Intra-Cellular Therapies, Inc. from 2014 to 2017.
He will be Chief Medical Officer at Relmada Therapeutics, Inc. in 2023 and was Chief Medical Officer at Alpha Cognition, Inc. from 2021 to 2023.
O'Gorman holds a doctorate from the National University of Ireland and an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC
0.03% | 23-05-2023 | 10 121 ( 0.03% ) | 47 063 $ | 31-03-2024 |
Eerdere bekende functies van Cedric O'Gorman
| Bedrijven | Functie | Einde |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03-01-2024 |
| ALPHA COGNITION INC. | Chief Tech/Sci/R&D Officer | 06-01-2023 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02-12-2021 |
| INTRA-CELLULAR THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 01-09-2017 |
Opleiding van Cedric O'Gorman
| National University of Ireland | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| RELMADA THERAPEUTICS, INC. | Health Technology |
| ALPHA COGNITION INC. | Health Technology |
